Inspecting the potential of thymol as a therapeutic agent for treating Alzheimer's disease

Inspecting the potential of thymol as a therapeutic agent for treating Alzheimer's disease

Thymol (2-isopropyl-5-methylphenol) is the main monoterpene phenol occurring in essential oils isolated from plants, like thyme, belonging to the Lemnaceae family.1 Due to its antioxidant, free radical scavenging, anti-inflammatory, analgesic, antispasmodic, antibacterial, antifungal and antisepti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Muhammad Waleed Imran, Sanwal Sardar Nawaz, Muhammad Moaz
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2024-10-01
Series:	Journal of the Pakistan Medical Association
Subjects:	thymol essential oils Neurodegenerative Diseases cognitive function Amyloid beta peptides neurofibrillary tangles
Online Access:	https://jpma.org.pk/index.php/public_html/article/view/10718
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
by: Julius Mulumba, et al.
Published: (2025-02-01)

The evolution of Alzheimer’s disease therapies: A comprehensive review
by: Pritama Paul, et al.
Published: (2024-01-01)

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
by: Tsu-Kung Lin, et al.
Published: (2024-11-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01)

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
by: Tapas Kumar Mohapatra, et al.
Published: (2025-06-01)

Inhibitory potential of polyphenolic stilbene derivatives with Glycogen Synthase Kinase-3β (GSK-3β) for Alzheimer's disease: Computational and SAR insights
by: Santosh Prasad Chaudhary Kurmi, et al.
Published: (2025-03-01)

Role of Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Clinical Diagnosed Alzheimer’s Diseases
by: Dilip Raj Timalsina, et al.
Published: (2025-05-01)

Impaired glymphatic clearance is an important cause of Alzheimer’s disease
by: Iyawnna Hazzard, et al.
Published: (2024-10-01)

Traumatic brain injury as a precursor to neurodegenerative diseases: Mechanisms linking TBI to Alzheimer’s disease
by: Kirti Bamel, et al.
Published: (2025-06-01)

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease
by: Guo Y, et al.
Published: (2016-02-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms
by: Souvik Adak, et al.
Published: (2025-08-01)

The past, present and future of Alzheimer's disease – part 1: the past
by: Ricardo Nitrini
Published: (2023-12-01)

Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues
by: Peizhou Jiang, et al.
Published: (2025-03-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
by: Julia C. Colwell, et al.
Published: (2025-07-01)

A Straightforward Electrochemical Approach for the Simultaneous Determination of Thymol and Carvacrol in Essential Oils
by: Sabrina Antonella Maccio, et al.
Published: (2024-09-01)

Identification of AmpC beta-lactamase producing clinical isolates of Klebsiella pneumoniae in Guilan and investigation of inhibitory effect of thymol on
by: Khorshid Jirdashtani, et al.
Published: (2024-08-01)

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition
by: Jie Xiang, et al.
Published: (2025-05-01)

Neuroprotective effect of ranolazine in mice's model of Alzheimer's disease
by: Mariam H. Sadiq, et al.
Published: (2024-06-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2
by: Gomaa Mostafa-Hedeab, et al.
Published: (2025-07-01)

Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01)

Anaesthetic profile of thymol and menthol in zebrafish larvae model
by: Raquel S.F. Vieira, et al.
Published: (2025-05-01)

Evaluation of the Antioxidant and Anti-Alzheimer’s Activity of Oleanolic Acid: An In-vitro Study
by: Viishaal Srikanth Srivatsa, et al.
Published: (2025-03-01)

Immunomodulatory effects of thymol and cinnamaldehyde in chicken cell lines
by: C. Shen, et al.
Published: (2020-07-01)

Chemical profiling and bioactivity evaluation of thymol rich Coleus aromaticus Benth. essential oil
by: Avneesh Rawat, et al.
Published: (2024-01-01)

Thymol combined with SAEW for the eradication of mature Pseudomonas aeruginosa biofilms and reduction of bacterial virulence
by: Zhexiao Ma, et al.
Published: (2025-06-01)

Fabrication of thymol-loaded polycaprolactone nanofiber membrane for freshness preservation
by: JIN Rong, et al.
Published: (2023-06-01)

In vitro antitrichomonal activity of Satureja khuzestanica and main essential oil components carvacrol, thymol, and eugenol
by: Faezeh Karami, et al.
Published: (2023-01-01)

Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
by: Lin Shiguo, et al.
Published: (2025-03-01)

Why testing and diagnosis for Alzheimer's disease are mission critical
by: Brent W. Beasley
Published: (2025-04-01)

Effect of thymol on planktonic and biofilm cells in drinking water: An anti-cryptosporidium effect
by: Chaimae Imane Sennouni, et al.
Published: (2025-08-01)

Catalpol alleviates amyloid- generation and neuronal oxidative stress injury via activating the Keap1-Nrf2/ARE signaling pathway in the immortalized lymphocytes from patients with late-onset Alzheimer’s disease and SKNMC cells co-culture model
by: Caixia Xiang, et al.
Published: (2024-12-01)

The impact of combined thymol and rosmarinic acid on the intestinal microbiota and barrier function of the piglets challenged by Escherichia coli K88
by: Runlin Li, et al.
Published: (2025-03-01)

Antifungal Efficacy of Thymol Powder Addition on Candida Albicans Adhesion to Room Temperature Vulcanized Maxillofacial Silicone: An In Vitro Study
by: Manar Hussein Ramadhan, et al.
Published: (2025-03-01)

Mechanisms of action and resistance prevention of synergistic thymol and carvacrol combinations with antibiotics in Staphylococcus aureus and Acinetobacter baumannii
by: Cristina Gan, et al.
Published: (2025-06-01)

Thymol and carvacrol against Klebsiella: anti-bacterial, anti-biofilm, and synergistic activities—a systematic review
by: Kousha Farhadi, et al.
Published: (2024-10-01)

Flow Injection Spectrophotometric Determination of Thymol using 4-Aminoantipyrine and Copper(II) Nitrate
by: Baghdad Science Journal
Published: (2015-06-01)

Role of melatonin in promoting growth attributes, thymol, rosmarinic acid and biochemical properties in Thymus vulgaris L. under water deficiency
by: Ghasem Eghlima, et al.
Published: (2025-05-01)

<strong>Ovicidal and adulticidal effects of synthetic menthol, thymol and their mixtures against <em>Tetranychus urticae </em>(Acari: Tetranychidae)</strong>
by: Mina Mohammadi, et al.
Published: (2015-01-01)